Surgical treatment to achieve cure

Keisuke Asakura, Shun Ichi Watanabe

Research output: Contribution to journalArticle

Abstract

The goal of surgical treatment for lung cancer is to achieve cure via complete tumor resection. Since the 1990s, the 5-year survival rate of lung cancer patients treated with surgical resection has increased remarkably in Japan. Three factors have contributed to the improvement of prognosis in these patients: 1) the increasing frequency of resection for small-sized lung cancers; 2) advancements in adjuvant chemotherapy for controlling micrometastases in stage IB-IIIA cases; and 3) progress in trimodality therapy for locally advanced lung cancers, including c III A/N2 disease and superior sulcus tumors. Given the increasing 5-year survival rate of patients treated with surgical resection, there have also been increases in the incidence of metachronous second lung cancer. We report our experiences with metachronous second lung cancer after surgical resection.

Original languageEnglish
Pages (from-to)710-722
Number of pages13
JournalJapanese Journal of Chest Diseases
Volume75
Issue number7
Publication statusPublished - 2016 Jul 1
Externally publishedYes

Fingerprint

Lung Neoplasms
Second Primary Neoplasms
Therapeutics
Survival Rate
Neoplasm Micrometastasis
Adjuvant Chemotherapy
Neoplasms
Japan
Incidence

Keywords

  • Early-stage lung cancer
  • Locally-advanced lung cancer
  • Metachronous second lung cancer
  • Multi-modality therapy
  • Surgical treatment

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Surgical treatment to achieve cure. / Asakura, Keisuke; Watanabe, Shun Ichi.

In: Japanese Journal of Chest Diseases, Vol. 75, No. 7, 01.07.2016, p. 710-722.

Research output: Contribution to journalArticle

Asakura, K & Watanabe, SI 2016, 'Surgical treatment to achieve cure', Japanese Journal of Chest Diseases, vol. 75, no. 7, pp. 710-722.
Asakura, Keisuke ; Watanabe, Shun Ichi. / Surgical treatment to achieve cure. In: Japanese Journal of Chest Diseases. 2016 ; Vol. 75, No. 7. pp. 710-722.
@article{fb80034a69a648aab1d451d3087c1bcd,
title = "Surgical treatment to achieve cure",
abstract = "The goal of surgical treatment for lung cancer is to achieve cure via complete tumor resection. Since the 1990s, the 5-year survival rate of lung cancer patients treated with surgical resection has increased remarkably in Japan. Three factors have contributed to the improvement of prognosis in these patients: 1) the increasing frequency of resection for small-sized lung cancers; 2) advancements in adjuvant chemotherapy for controlling micrometastases in stage IB-IIIA cases; and 3) progress in trimodality therapy for locally advanced lung cancers, including c III A/N2 disease and superior sulcus tumors. Given the increasing 5-year survival rate of patients treated with surgical resection, there have also been increases in the incidence of metachronous second lung cancer. We report our experiences with metachronous second lung cancer after surgical resection.",
keywords = "Early-stage lung cancer, Locally-advanced lung cancer, Metachronous second lung cancer, Multi-modality therapy, Surgical treatment",
author = "Keisuke Asakura and Watanabe, {Shun Ichi}",
year = "2016",
month = "7",
day = "1",
language = "English",
volume = "75",
pages = "710--722",
journal = "Japanese Journal of Chest Diseases",
issn = "0385-3667",
publisher = "Kokuseido Publishing Co. Ltd",
number = "7",

}

TY - JOUR

T1 - Surgical treatment to achieve cure

AU - Asakura, Keisuke

AU - Watanabe, Shun Ichi

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The goal of surgical treatment for lung cancer is to achieve cure via complete tumor resection. Since the 1990s, the 5-year survival rate of lung cancer patients treated with surgical resection has increased remarkably in Japan. Three factors have contributed to the improvement of prognosis in these patients: 1) the increasing frequency of resection for small-sized lung cancers; 2) advancements in adjuvant chemotherapy for controlling micrometastases in stage IB-IIIA cases; and 3) progress in trimodality therapy for locally advanced lung cancers, including c III A/N2 disease and superior sulcus tumors. Given the increasing 5-year survival rate of patients treated with surgical resection, there have also been increases in the incidence of metachronous second lung cancer. We report our experiences with metachronous second lung cancer after surgical resection.

AB - The goal of surgical treatment for lung cancer is to achieve cure via complete tumor resection. Since the 1990s, the 5-year survival rate of lung cancer patients treated with surgical resection has increased remarkably in Japan. Three factors have contributed to the improvement of prognosis in these patients: 1) the increasing frequency of resection for small-sized lung cancers; 2) advancements in adjuvant chemotherapy for controlling micrometastases in stage IB-IIIA cases; and 3) progress in trimodality therapy for locally advanced lung cancers, including c III A/N2 disease and superior sulcus tumors. Given the increasing 5-year survival rate of patients treated with surgical resection, there have also been increases in the incidence of metachronous second lung cancer. We report our experiences with metachronous second lung cancer after surgical resection.

KW - Early-stage lung cancer

KW - Locally-advanced lung cancer

KW - Metachronous second lung cancer

KW - Multi-modality therapy

KW - Surgical treatment

UR - http://www.scopus.com/inward/record.url?scp=84982311216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982311216&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84982311216

VL - 75

SP - 710

EP - 722

JO - Japanese Journal of Chest Diseases

JF - Japanese Journal of Chest Diseases

SN - 0385-3667

IS - 7

ER -